AARON GALBRAITH

Allopathic & Osteopathic Physicians|Internal Medicine PLEASANT PRAIRIE, WI NPI 1871835124

General Payments — all program years on this page

$796.91

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 42
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $453.59 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $453.5922

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $99.436
2023 $243.8914
2024 $453.5922

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086797037 Novartis Pharmaceuticals Corporation $25.21 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086797039 Novartis Pharmaceuticals Corporation $16.68 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086797045 Novartis Pharmaceuticals Corporation $21.27 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086797053 Novartis Pharmaceuticals Corporation $24.66 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096779403 Novo Nordisk Inc $17.77 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097782080 Novo Nordisk Inc $21.14 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097823136 Novo Nordisk Inc $17.89 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104317576 AstraZeneca Pharmaceuticals LP $22.05 11/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104319488 AstraZeneca Pharmaceuticals LP $16.22 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105608087 AstraZeneca Pharmaceuticals LP $21.55 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114666047 Exact Sciences Corporation $18.27 02/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114666053 Exact Sciences Corporation $17.50 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116142279 GlaxoSmithKline, LLC. $18.10 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116382626 GlaxoSmithKline, LLC. $24.11 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116425511 GlaxoSmithKline, LLC. $21.00 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116605248 GlaxoSmithKline, LLC. $18.22 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118205745 Boehringer Ingelheim Pharmaceuticals, Inc. $16.16 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118205749 Boehringer Ingelheim Pharmaceuticals, Inc. $23.87 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136001047 Lilly USA, LLC $25.64 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136001049 Lilly USA, LLC $21.97 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136003314 Lilly USA, LLC $25.68 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145916995 Lundbeck LLC $18.63 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.